Parkside Financial Bank & Trust grew its holdings in shares of The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 65.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 96 shares of the medical device company's stock after purchasing an additional 38 shares during the period. Parkside Financial Bank & Trust's holdings in Cooper Companies were worth $30,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Riverview Trust Co acquired a new stake in shares of Cooper Companies during the first quarter worth $29,000. Capital Advisors Ltd. LLC raised its holdings in shares of Cooper Companies by 223.1% during the first quarter. Capital Advisors Ltd. LLC now owns 126 shares of the medical device company's stock worth $53,000 after purchasing an additional 87 shares during the period. Fieldpoint Private Securities LLC raised its holdings in shares of Cooper Companies by 180.0% during the first quarter. Fieldpoint Private Securities LLC now owns 140 shares of the medical device company's stock worth $58,000 after purchasing an additional 90 shares during the period. NuWave Investment Management LLC acquired a new stake in shares of Cooper Companies during the second quarter worth $54,000. Finally, US Asset Management LLC acquired a new stake in shares of Cooper Companies during the first quarter worth $81,000. 97.09% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on COO shares. TheStreet cut shares of Cooper Companies from a "b-" rating to a "c+" rating in a report on Monday, July 18th. Piper Sandler dropped their price objective on shares of Cooper Companies from $425.00 to $375.00 and set an "overweight" rating on the stock in a report on Friday, July 8th. Wells Fargo & Company dropped their price objective on shares of Cooper Companies from $370.00 to $365.00 and set an "overweight" rating on the stock in a report on Thursday, September 1st. KeyCorp dropped their price objective on shares of Cooper Companies from $414.00 to $408.00 and set an "overweight" rating on the stock in a report on Friday, June 3rd. Finally, Stephens dropped their price objective on shares of Cooper Companies from $500.00 to $460.00 and set an "overweight" rating on the stock in a report on Friday, June 3rd. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus price target of $406.00.

Cooper Companies Stock Up 0.5 %

Cooper Companies (NYSE:COO – Get Rating) last released its earnings results on Wednesday, August 31st. The medical device company reported $3.19 EPS for the quarter, missing the consensus estimate of $3.20 by ($0.01). The company had revenue of $843.40 million for the quarter, compared to analyst estimates of $830.22 million. Cooper Companies had a net margin of 13.38% and a return on equity of 9.22%. The firm's quarterly revenue was up 10.5% on a year-over-year basis. During the same period in the previous year, the business posted $3.41 EPS. On average, analysts expect that The Cooper Companies, Inc. will post 12.79 EPS for the current fiscal year.

Cooper Companies Announces Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, August 11th. Investors of record on Wednesday, July 27th were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Tuesday, July 26th. Cooper Companies's dividend payout ratio is 0.69%.

Cooper Companies Profile

(Get Rating)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

See Also

• Get a free copy of the StockNews.com research report on Cooper Companies (COO)
• Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
• MarketBeat: Week in Review 9/19 – 9/23
• Why Does Tesla Stock Remain Resilient?
• 2 Semiconductor Stocks To Watch For Reversals
• Will Crowdstrike Get A Boost From Increased EPS Guidance?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COO – Get Rating).

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.